495 related articles for article (PubMed ID: 30291498)
1. Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing.
Yoo KH; Hennighausen L; Shin HY
J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):47-59. PubMed ID: 30291498
[TBL] [Abstract][Full Text] [Related]
2. STAT5-Driven Enhancers Tightly Control Temporal Expression of Mammary-Specific Genes.
Shin HY; Hennighausen L; Yoo KH
J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):61-71. PubMed ID: 30328555
[TBL] [Abstract][Full Text] [Related]
3. Identifying Novel Enhancer Elements with CRISPR-Based Screens.
Klein JC; Chen W; Gasperini M; Shendure J
ACS Chem Biol; 2018 Feb; 13(2):326-332. PubMed ID: 29300083
[TBL] [Abstract][Full Text] [Related]
4. Mammary-Enriched Transcription Factors Synergize to Activate the
Kim U; Kim S; Kim N; Shin HY
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232979
[TBL] [Abstract][Full Text] [Related]
5. Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing.
Li K; Liu Y; Cao H; Zhang Y; Gu Z; Liu X; Yu A; Kaphle P; Dickerson KE; Ni M; Xu J
Nat Commun; 2020 Jan; 11(1):485. PubMed ID: 31980609
[TBL] [Abstract][Full Text] [Related]
6. An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome.
Hay EA; Khalaf AR; Marini P; Brown A; Heath K; Sheppard D; MacKenzie A
Neuropeptides; 2017 Aug; 64():101-107. PubMed ID: 27866656
[TBL] [Abstract][Full Text] [Related]
7. No unexpected CRISPR-Cas9 off-target activity revealed by trio sequencing of gene-edited mice.
Iyer V; Boroviak K; Thomas M; Doe B; Riva L; Ryder E; Adams DJ
PLoS Genet; 2018 Jul; 14(7):e1007503. PubMed ID: 29985941
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 for Human Genome Engineering and Disease Research.
Xiong X; Chen M; Lim WA; Zhao D; Qi LS
Annu Rev Genomics Hum Genet; 2016 Aug; 17():131-54. PubMed ID: 27216776
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 editing of non-coding genomic loci as a means of controlling gene expression in the sea urchin.
Pieplow A; Dastaw M; Sakuma T; Sakamoto N; Yamamoto T; Yajima M; Oulhen N; Wessel GM
Dev Biol; 2021 Apr; 472():85-97. PubMed ID: 33482173
[TBL] [Abstract][Full Text] [Related]
10. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
[TBL] [Abstract][Full Text] [Related]
11. Applying CRISPR-Cas9 tools to identify and characterize transcriptional enhancers.
Lopes R; Korkmaz G; Agami R
Nat Rev Mol Cell Biol; 2016 Sep; 17(9):597-604. PubMed ID: 27381243
[TBL] [Abstract][Full Text] [Related]
12. Functional assessment of CTCF sites at cytokine-sensing mammary enhancers using CRISPR/Cas9 gene editing in mice.
Lee HK; Willi M; Wang C; Yang CM; Smith HE; Liu C; Hennighausen L
Nucleic Acids Res; 2017 May; 45(8):4606-4618. PubMed ID: 28334928
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 for Mutagenesis in Rice.
Char SN; Li R; Yang B
Methods Mol Biol; 2019; 1864():279-293. PubMed ID: 30415343
[TBL] [Abstract][Full Text] [Related]
14. A Multiplexed CRISPR/Cas9 Editing System Based on the Endogenous tRNA Processing.
Xie K; Yang Y
Methods Mol Biol; 2019; 1917():63-73. PubMed ID: 30610628
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
16. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
17. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
Kumar R; Tiwari K; Saudagar P
Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
[TBL] [Abstract][Full Text] [Related]
18. Efficient CRISPR/Cas9-based genome editing in carrot cells.
Klimek-Chodacka M; Oleszkiewicz T; Lowder LG; Qi Y; Baranski R
Plant Cell Rep; 2018 Apr; 37(4):575-586. PubMed ID: 29332168
[TBL] [Abstract][Full Text] [Related]
19. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Regulatory Elements with All-in-One CRISPR-Cas9 Vectors.
Cebola I
Methods Mol Biol; 2021; 2351():321-334. PubMed ID: 34382198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
